{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:21:40Z","timestamp":1778728900624,"version":"3.51.4"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RAAIDD"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>Cutaneous candidiasis is a deep-seated skin fungal infection that\nis most commonly observed in immunocompromised patients. This fungal infection is\nconventionally treated with various formulations like gels and creams which are having\ndifferent side effects and the least therapeutic efficacy. Hence, it becomes necessary to\ndevelop a novel carrier system for the treatment of this deep-seated skin fungal infection.\nEconazole nitrate is the most widely used antifungal for the treatment of cutaneous candidiasis\nand many patents have been granted by various pharmaceutical scientists around\nthe globe related to nanocarrier systems for transdermal delivery of antifungal drugs like\neconazole nitrate (ECN) therefore, we developed and evaluated econazole nitrate loaded\noleic acid vesicles in the present research work for treatment of cutaneous candidiasis\nthrough transdermal route.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods::<\/jats:title>\n<jats:p>Econazole nitrate loaded oleic acid vesicles were prepared by thin-film hydration\nand characterized for drug entrapment, vesicle size, zeta potential, polydispersity index\n(PDI), Fourier Transform-infrared spectroscopy (FT-IR), differential scanning\ncalorimetry (DSC), and X-ray diffraction (XRD) analysis. Furthermore, the oleic acid\nvesicular gel was evaluated for ex-vivo skin permeation\/retention and in-vitro and in-vivo\nantifungal activity in Wistar rats.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>Econazole nitrate loaded oleic acid vesicles showed high encapsulation of drug\n(74.76 \u00b1 3.0%), acceptable size (373.4 \u00b1 2.9 nm), and colloidal characteristics (PDI =\n0.231 \u00b1 0.078, and zeta potential = -13.27 \u00b1 0.80 mV). The oleic acid vesicular gel\nshowed high skin permeation (Transdermal flux = 61.98 \u00b1 2.45 \u03bcg\/cm2\/h), skin retention\n(35.90 \u00b1 2.06%), in-vitro, and in-vivo antifungal activity compared to marketed cream (Ecoderm\nR) of econazole nitrate for a prolonged time (4 days).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>Developed econazole nitrate loaded oleic acid vesicles could be used effectively\nin the treatment of cutaneous candidiasis with minimization of side effects of econazole\nnitrate with increased therapeutic efficacy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574891x15999201110212725","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T05:18:46Z","timestamp":1605158326000},"page":"30-49","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oleic Acid Vesicles as a New Approach for Transdermal Delivery of Econazole Nitrate: Development, Characterization, and In-vivo Evaluation in Wistar Rats"],"prefix":"10.2174","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1367-5299","authenticated-orcid":true,"given":"Shivani","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Rayat-Bahra College of Pharmacy, Hoshiarpur, Punjab 146001,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6551-5599","authenticated-orcid":true,"given":"Puneet","family":"Utreja","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Department of Pharmaceutics, PCTE Group of Institutes, Ludhiana, Punjab 142021,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1517\/17425247.5.7.737","volume":"5","author":"Cosco D.","year":"2008","unstructured":"Cosco D.; Celia C.; Cilurzo F.; Trapasso E.; Paolino D.; Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv 2008,5(7),737-755","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/21691401.2014.883401","volume":"43","author":"Singh D.","year":"2015","unstructured":"Singh D.; Pradhan M.; Nag M.; Vesicular system: Versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol 2015,43(4),282-290","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1517\/17425240903071029","volume":"6","author":"Sinico C.","year":"2009","unstructured":"Sinico C.; Fadda A.M.; Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 2009,6(8),813-825","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.addr.2003.10.028","volume":"56","author":"Cevc G.","year":"2004","unstructured":"Cevc G.; Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004,56(5),675-711","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.addr.2003.10.028","volume":"56","author":"Cevc G.","year":"2004","unstructured":"Cevc G.; Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 2004,56(5),675-711","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.actatropica.2019.05.018","volume":"196","author":"Kavian Z.","year":"2019","unstructured":"Kavian Z.; Alavizadeh S.H.; Golmohamadzadeh S.; Badiee A.; Khamesipour A.; Jaafari M.R.; Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB\/c mice. Acta Trop 2019,196,142-149","journal-title":"Acta Trop"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10717540801952407","volume":"15","author":"Jain S.K.","year":"2008","unstructured":"Jain S.K.; Gupta Y.; Jain A.; Rai K.; Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 2008,15(3),141-147","journal-title":"Drug Deliv"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/1567201814666170224141548","volume":"15","author":"El-Ridy M.S.","year":"2018","unstructured":"El-Ridy M.S.; Yehia S.A.; Mohsen A.M.; El-Awdan S.A.; Darwish A.B.; Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo  Evaluation. Curr Drug Deliv 2018,15(1),122-133","journal-title":"Curr Drug Deliv"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/php.12121","volume":"89","author":"da Silva C.L.","year":"2013","unstructured":"da Silva C.L.; Del Ciampo J.O.; Rossetti F.C.; Bentley M.V.; Pierre M.B.; Improved in vitro and in vivo  cutaneous delivery of protoporphyrin IX from PLGA-based nanoparticles. Photochem Photobiol 2013,89(5),1176-1184","journal-title":"Photochem Photobiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3109\/08982104.2015.1117490","volume":"26","author":"Kurakula M.","year":"2016","unstructured":"Kurakula M.; Ahmed O.A.; Fahmy U.A.; Ahmed T.A.; Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. J Liposome Res 2016,26(4),288-296","journal-title":"J Liposome Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"E104","DOI":"10.1208\/pt0804104","volume":"8","author":"Shakeel F.","year":"2007","unstructured":"Shakeel F.; Baboota S.; Ahuja A.; Ali J.; Aqil M.; Shafiq S.; Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 2007,8(4),E104","journal-title":"AAPS PharmSciTech"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/10837450.2019.1578371","volume":"24","author":"Bahl D.","year":"2019","unstructured":"Bahl D.; Daftardar S.; Devi Bachu R.; Boddu S.H.S.; Altorok N.; Kahaleh B.; Evaluation of topical econazole nitrate formulations with potential for treating Raynaud\u2019s phenomenon. Pharm Dev Technol 2019,24(6),689-699","journal-title":"Pharm Dev Technol"},{"key":"ref=13","first-page":"278","volume":"35","author":"Daily A.D.","year":"1985","unstructured":"Daily A.D.; Kramer K.J.; Rex I.H.; Thorne E.G.; Econazole nitrate (Spectazole) cream, 1 percent: a topical agent for the treatment of tinea pedis. Cutis 1985,35(3),278-280","journal-title":"Cutis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/14728214.2011.607811","volume":"16","author":"Pitman S.K.","year":"2011","unstructured":"Pitman S.K.; Drew R.H.; Perfect J.R.; Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations. Expert Opin Emerg Drugs 2011,16(3),559-586","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.actbio.2019.10.024","volume":"101","author":"Na Y.G.","year":"2020","unstructured":"Na Y.G.; Huh H.W.; Kim M.K.; Byeon J.J.; Han M.G.; Lee H.K.; Cho C.W.; Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes. Acta Biomater 2020,101,507-518","journal-title":"Acta Biomater"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3109\/03639045.2010.529144","volume":"37","author":"da Silva E.R.","year":"2011","unstructured":"da Silva E.R.; de Freitas Z.M.; Gitirana Lde.B.; Ricci-J\u00fanior E.; Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention. Drug Dev Ind Pharm 2011,37(5),569-575","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/21691401.2016.1146729","volume":"45","author":"Kumar L.","year":"2017","unstructured":"Kumar L.; Verma S.; Kumar S.; Prasad D.N.; Jain A.K.; Fatty acid vesicles acting as expanding horizon for transdermal delivery. Artif Cells Nanomed Biotechnol 2017,45(2),251-260","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1016368714631","volume":"3","author":"Murakami M.","year":"1986","unstructured":"Murakami M.; Yoshikawa H.; Takada K.; Muranishi S.; Effect of oleic Acid vesicles on intestinal absorption of carboxyfluorescein in rats. Pharm Res 1986,3(1),35-40","journal-title":"Pharm Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.3390\/medicines5030103","volume":"5","author":"Kumar P.","year":"2018","unstructured":"Kumar P.; Singh S.K.; Handa V.; Kathuria H.; Oleic Acid Nanovesicles of Minoxidil for Enhanced Follicular Delivery. Medicines 2018,5(3),E103","journal-title":"Medicines"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3109\/10717541003680981","volume":"17","author":"Zakir F.","year":"2010","unstructured":"Zakir F.; Vaidya B.; Goyal A.K.; Malik B.; Vyas S.P.; Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Drug Deliv 2010,17(4),238-248","journal-title":"Drug Deliv"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"680580","DOI":"10.1155\/2013\/680580","volume":"2013","author":"Mittal R.","year":"2013","unstructured":"Mittal R.; Sharma A.; Arora S.; Ufasomes mediated cutaneous delivery of dexamethasone: formulation and evaluation of anti-inflammatory activity by carrageenin-induced rat paw edema model. J Pharm 2013,2013,680580","journal-title":"J Pharm"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ijpharm.2012.11.013","volume":"441","author":"Tan H.W.","year":"2013","unstructured":"Tan H.W.; Misran M.; Polysaccharide-anchored fatty acid liposome. Int J Pharm 2013,441(1-2),414-423","journal-title":"Int J Pharm"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08982104.2014.950276","volume":"25","author":"Ahmed T.A.","year":"2015","unstructured":"Ahmed T.A.; Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett-Burman design and characterization. J Liposome Res 2015,25(1),1-10","journal-title":"J Liposome Res"},{"key":"ref=24","first-page":"2431","volume":"9","author":"Ali M.F.M.","year":"2015","unstructured":"Ali M.F.M.; Salem H.F.; Abdelmohsen H.F.; Attia S.K.; Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction. Drug Des Devel Ther 2015,9,2431-2447","journal-title":"Drug Des Devel Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.4103\/0250-474X.49119","volume":"70","author":"Gupta V.","year":"2008","unstructured":"Gupta V.; Barupal A.K.; Ramteke S.; Formulation Development and in vitro Characterization of Proliposomes for Topical Delivery of Aceclofenac. Indian J Pharm Sci 2008,70(6),768-775","journal-title":"Indian J Pharm Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/2211738506666180209100222","volume":"6","author":"Khan S.","year":"2018","unstructured":"Khan S.; Jain P.; Jain S.; Jain R.; Bhargava S.; Jain A.; Topical Delivery of Erythromycin Through Cubosomes for Acne. Pharm Nanotechnol 2018,6(1),38-47","journal-title":"Pharm Nanotechnol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2147\/IJN.S201356","volume":"14","author":"Omar M.M.","year":"2019","unstructured":"Omar M.M.; Hasan O.A.; El Sisi A.M.; Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for enhancement of skin permeation. Int J Nanomedicine 2019,14,1551-1562","journal-title":"Int J Nanomedicine"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1208\/aapsj060326","volume":"6","author":"Mohamed M.I.","year":"2004","unstructured":"Mohamed M.I.; Optimization of chlorphenesin emulgel formulation. AAPS J 2004,6(3),e26","journal-title":"AAPS J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2147\/IJN.S201356","volume":"14","author":"Omar M.M.","year":"2019","unstructured":"Omar M.M.; Hasan O.A.; El Sisi A.M.; Preparation and\noptimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for\nenhancement of skin permeation. Int J Nanomedicine 2019,14,1551-1562","journal-title":"Int J Nanomedicine"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jsps.2017.01.006","volume":"25","author":"Ahad A.","year":"2017","unstructured":"Ahad A.; Al-Saleh A.A.; Al-Mohizea A.M.; Al-Jenoobi F.I.; Raish M.; Yassin A.E.B.; Alam M.A.; Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate. Saudi Pharm J 2017,25(7),1040-1046","journal-title":"Saudi Pharm J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/pharmaceutics3040954","volume":"3","author":"Nava G.","year":"2011","unstructured":"Nava G.; Pi\u00f1\u00f3n E.; Mendoza L.; Mendoza N.; Quintanar D.; Ganem A.; Formulation and in Vitro, ex Vivo and in Vivo Evaluation of Elastic Liposomes for Transdermal Delivery of Ketorolac Tromethamine. Pharmaceutics 2011,3(4),954-970","journal-title":"Pharmaceutics"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2126056","DOI":"10.1155\/2016\/2126056","volume":"2016","author":"Ali A.M.","year":"2016","unstructured":"Ali A.M.; Al-Remawi M.M.; Freeze Dried Quetiapine-Nicotinamide Binary Solid Dispersions: A New Strategy for Improving Physicochemical Properties and Ex Vivo Diffusion. J Pharm 2016,2016,2126056","journal-title":"J Pharm"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.22159\/ajpcr.2018.v11s2.28563","volume":"11","author":"Kaur P.","year":"2018","unstructured":"Kaur P.; Garg V.; Bawa P.; Formulation; systematic optimization; in vitro; ex vivo; and stability assessment of transethosome based gel of curcumin. Asi J Pharm Clin Res 2018,11(2),41-47","journal-title":"Asi J Pharm Clin Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/08982101003596125","volume":"20","author":"Gupta M.","year":"2010","unstructured":"Gupta M.; Goyal A.K.; Paliwal S.R.; Paliwal R.; Mishra N.; Vaidya B.; Dube D.; Jain S.K.; Vyas S.P.; Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res 2010,20(4),341-350","journal-title":"J Liposome Res"},{"key":"ref=35","first-page":"376","volume":"6","author":"Raja J.","year":"2014","unstructured":"Raja J.; Muralidharan S.; Parasuraman S.; In Vitro and in Vivo evaluation of microspheres loaded topical gel delivery system of ketoconazole in male rats against Candida Glabrata. J Pharm Sci Res 2014,6,376-381","journal-title":"J Pharm Sci Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1208\/s12249-012-9754-y","volume":"13","author":"Akhtar N.","year":"2012","unstructured":"Akhtar N.; Pathak K.; Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel. AAPS PharmSciTech 2012,13(1),344-355","journal-title":"AAPS PharmSciTech"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/02681219480000471","volume":"32","author":"Maebashi K.","year":"1994","unstructured":"Maebashi K.; Itoyama T.; Uchida K.; Suegara N.; Yamaguchi H.; A novel model of cutaneous candidiasis produced in prednisolone-treated guinea-pigs. J Med Vet Mycol 1994,32(5),349-359","journal-title":"J Med Vet Mycol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3109\/10837450.2013.778874","volume":"19","author":"Kumar L.","year":"2014","unstructured":"Kumar L.; Verma S.; Jamwal S.; Vaidya S.; Vaidya B.; Polymeric microparticles-based formulation for the eradication of cutaneous candidiasis: development and characterization. Pharm Dev Technol 2014,19(3),318-325","journal-title":"Pharm Dev Technol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chemphyslip.2012.01.006","volume":"165","author":"Gupta M.","year":"2012","unstructured":"Gupta M.; Vyas S.P.; Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids 2012,165(4),454-461","journal-title":"Chem Phys Lipids"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1556\/JPC.17.2004.2.5","volume":"17","author":"Popovi\u0107 G","year":"2004","unstructured":"Popovi\u0107 G; \u010cakar M; Vu\u010di\u0107evi\u0107 K; Vladimirov S; Agbaba D.; Comparison of HPTLC and HPLC for determination of econazole nitrate in topical dosage forms JPC - J Planar Chromat 2004,17(2),109-12","journal-title":"JPC - J Planar Chromat"},{"key":"ref=41","first-page":"424","volume":"9","author":"Kaur N.","year":"2017","unstructured":"Kaur N.; Garg R.; Optimization and Evaluation of Oleic Acid Based Unsaturated Fatty Acid Liposomes Gel. J Bioequivalence Bioavailab 2017,9,424-429","journal-title":"J Bioequivalence Bioavailab"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/10837450.2017.1330345","volume":"23","author":"Ahad A.","year":"2018","unstructured":"Ahad A.; Al-Saleh A.A.; Al-Mohizea A.M.; Al-Jenoobi F.I.; Raish M.; Yassin A.E.B.; Alam M.A.; Formulation and characterization of Phospholipon 90\u2009G and tween 80 based transfersomes for transdermal delivery of eprosartan mesylate. Pharm Dev Technol 2018,23(8),787-793","journal-title":"Pharm Dev Technol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","volume":"397","author":"El Zaafarany G.M.","year":"2010","unstructured":"El Zaafarany G.M.; Awad G.A.; Holayel S.M.; Mortada N.D.; Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 2010,397(1-2),164-172","journal-title":"Int J Pharm"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1081\/DDC-120025458","volume":"29","author":"Jain S.","year":"2003","unstructured":"Jain S.; Jain P.; Umamaheshwari R.B.; Jain N.K.; Transfersomes- a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 2003,29(9),1013-1026","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/305863","volume":"2014","author":"Gajra B","year":"2014","unstructured":"Gajra B; Pandya SS; Singh S; Rabari HA; Mucoadhesive hydrogel films of econazole nitrate: formulation and optimization using factorial design. Journal Drug Del 2014,2014","journal-title":"Journal Drug Del"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.jddst.2019.101418","volume":"55","author":"Malik D.S.","year":"2020","unstructured":"Malik D.S.; Kaur G.; Exploring therapeutic potential of azelaic acid loaded NLCs for the treatment of acne vulgaris. J Drug Deliv Sci Technol 2020,55,101418","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Recent Advances in Anti-Infective Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/187823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187823\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/187823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T05:40:30Z","timestamp":1643780430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187823\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574891x15999201110212725","relation":{},"ISSN":["2772-4344"],"issn-type":[{"value":"2772-4344","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}